Anti-Human FGFR1 Antibody [B855]
Anti-Human FGFR1 Antibody [B855] with collaborator-tested evidence for WB, IHC, IF/ICC, IP, ELISA. Read more ›
["WBProduct Description
FGFR1 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Monoclonal; clone: B855; isotype: IgG,κ; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for WB, IHC, IF, IP, ELISA. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Recombinant Human FGFR1 protein; purification: Protein A; concentration: 0.2 mg/mL.
Database references: UniProt: P11362.
Research Use Only.
Key Facts
| Target | FGFR1 |
| Also known as | KAL, bFGF-R, FLT, FGFR1, BFGFR, CD331, CEK, ECCL, FGFBR, FGFR-1, FLG, FLT-2, FLT2, HBGFR, HH2, HRTFDS, KAL2, N-SAM, OGD, bFGF-R-1, FLG, FLT2, N-SAM, Basic fibroblast growth factor receptor 1, FGFR 1, FGFR1/PLAG1 fusion, fibroblast growth factor receptor 1, Fms-like gene, Fms-like tyrosine kinase 2, fms-related tyrosine kinase 2, heparin-binding growth factor receptor, hydroxyaryl-protein kinase, Proto-oncogene c-Fgr, FGF Receptor 1 |
| Concentration | 0.2 mg/mL |
| Species reactivity | Human |
| Observed band | 145 kDa |
| Shelf life | 12 months from shipping dates |
| Research area | Cardiovascular, Signal Transduction, Neuroscience, Cancer, Epigenetics and Nuclear Signaling |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | IHC | ELISA | |
|---|---|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.